Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer

被引:92
|
作者
Rollin, Jerome
Regina, Sandra
Vourc'h, Patrick
Iochmann, Sophie
Blechet, Claire
Reverdiau, Pascale
Gruel, Yves
机构
[1] Fac Med Tours, INSERM, U618, F-37032 Tours, France
[2] IFR 135, F-37000 Tours, France
[3] INSERM, U619, F-37000 Tours, France
关键词
MMP-2; MMP-9; TFPI-2; non-small cell lung cancer; polymorphism; gene expression; prognosis;
D O I
10.1016/j.lungcan.2006.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases (MMP) including MMP-2 and MMP-9 play a major role in tumour invasion by proteolysing the extracellular matrix. Their activation, particularly that of MMP-9, is partly dependent on plasmin that is inhibited by TFPI-2 (tissue factor pathway inhibitor-2), a serine protease inhibitor whose gene expression is decreased in about one-third of non-small cell lung cancers (NSCLC). In addition, MMP-2 and MMP-9 are essential in the development of NSCLC and can be regulated by functional promoter polymorphisms. In this study, the -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 polymorphisms were analysed in 90 NSCLC patients and 90 controls. In addition, the promoter region of the TFPI-2 gene was screened for sequence variations in both groups by DHPLC. A -167G/A polymorphism was identified in 3% of controls whereas none of the 90 patients exhibited this genetic variation in the TFPI-2 promoter region. Moreover, no difference in -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 genotypes was found between cases and controls. However, the homozygous -1562CC MMP-9 genotype was more frequent in patients with squamous cell carcinoma than in controls (p=0.018). When genotype distributions were compared to MMP-2 and MMP-9 gene expression in tumours, no relationship was found with the -1306 MMP-2 and -1562 MMP-9 polymorphisms. In contrast, tumour MMP-2 gene expression was tower in homozygous -735CC patients than in those with CT or TT genotypes. In addition, the survival time was longer in patients with the MMP-2 -735T allele than in those with the CC genotype (p = 0.02). The relative risk of death was increased 2.6-fold in -735CC patients (p = 0.045; 95% CI = 1.0-6.7). The results of this study suggest that the -735C/T MMP-2 polymorphism might be an independent prognostic marker in NSCLC, but this should be confirmed in a larger cohort of patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [21] Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype
    Grieu, F
    Li, WQ
    Iacopetta, B
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (03) : 197 - 204
  • [22] Different expression patterns of MMP-2 and MMP-9 in breast cancer
    Rha, SY
    Yang, WI
    Kim, JH
    Roh, JK
    Min, JS
    Lee, KS
    Kim, BS
    Chung, HC
    ONCOLOGY REPORTS, 1998, 5 (04) : 875 - 879
  • [23] Expression of MMP-2 and MMP-9 in oral squamous cell carcinomas
    Hong, SD
    Lee, JI
    Hong, SP
    Lim, CY
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 522 - 522
  • [24] The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis
    Yan, Yulan
    Liang, Hongjie
    Li, Taijie
    Li, Meng
    Li, Ruolin
    Qin, Xue
    Li, Shan
    TUMOR BIOLOGY, 2014, 35 (04) : 3047 - 3052
  • [25] The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer
    Butkiewicz, Dorota
    Krzesniak, Malgorzata
    Drosik, Anna
    Giglok, Monika
    Gdowicz-Klosok, Agnieszka
    Kosarewicz, Agata
    Rusin, Marek
    Maslyk, Barbara
    Gawkowska-Suwinska, Marzena
    Suwinski, Rafal
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (10) : 2332 - 2342
  • [26] Clinical significance of MMP-2 and MMP-9 in patients with oral cancer
    Patel, Beena P.
    Shah, Shakuntala V.
    Shukla, Shilin N.
    Shah, Pankaj M.
    Patel, Prabhudas S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (06): : 564 - 572
  • [28] Expression of MMP-2 and MMP-9 in retinoblastoma and their significance
    Long, Hua
    Zhou, Bo
    Jiang, Fa-Gang
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (05) : 489 - 491
  • [29] Expression of E-cadherin, MMP-2 and HSP in non-small cell lung cancer
    Hosny, G.
    Abd Elfatah, N. K.
    Tayel, H.
    EJC SUPPLEMENTS, 2008, 6 (09): : 197 - 197
  • [30] Functional polymorphisms in the promoter region of MMP-2 and MMP-9 and susceptibility to obstructive sleep apnea
    Cao, Chao
    Wu, Bin
    Wu, Yanping
    Yu, Yiming
    Ma, Hongying
    Sun, Shifang
    Zhang, Qiaoli
    Ding, Qunli
    Chen, Li
    Deng, Zaichun
    SCIENTIFIC REPORTS, 2015, 5